When applied to the continuous monitoring of HER-2 type breast cancer, a point mutation in phosphatidylinositol-4,5-bisphosphate 3-kinase (PIK3CA) was detected, in a liver metastasis [116]. This evidence concerns the gene ERBB2 and breast cancer.